NBD AI Bulletin - Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SH 603392, close price: 138.13 yuan) announced on August 12 that the company has decided at a meeting on August 5 to buy back shares with no less than 200 million yuan and no more than 400 million yuan, with the repurchase price not exceeding about 224 yuan/share.

In 2021, the operating revenue of the Company was made up of vaccines (58.48%) and in vitro diagnoses (40.68%).

Beijing Wantai Biological Pharmacy Enterprise's chairman and general manager is Qiu Zixin, male, 59 years old, undergraduate.

As at the press time, the market value of Beijing Wantai Biological Pharmacy Enterprise Co Ltd was 125.2 billion yuan.

(By Lan Suying)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.